DURECT Corporation (DRRX) Social Stream
DURECT CORP (DRRX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering DRRX.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-11 | 3 | $7 | $6 | $6.25 | $6.45 | -3.1% |
| 2021-12-23 | 2 | $6 | $6 | $6 | $6.45 | -6.98% |
| 2022-05-05 | 2 | $6 | $5 | $5.666 | $6.45 | -12.16% |
| 2022-08-05 | 3 | $6 | $5 | $5.666 | $6.45 | -12.16% |
| 2022-11-03 | 3 | $6 | $4 | $5.333 | $6.45 | -17.32% |
| 2022-12-07 | 3 | $40 | $32 | $35.666 | $6.45 | 452.96% |
| 2022-12-16 | 2 | $37 | $32 | $34.666 | $6.45 | 437.46% |
| 2023-03-08 | 3 | $37 | $32 | $34.666 | $6.45 | 437.46% |
| 2023-05-09 | 3 | $44 | $32 | $36 | $6.45 | 458.14% |
The Trend in the Analyst Price Target
DRRX's average price target has moved up $29.5 over the prior 21 months.
Over the past 40 weeks, DRRX's average upside potential has been 1,462.9%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-09-26 | 3 | 6 | 4 | 5.333 | 0.565 | 843.89% |
| 2022-12-16 | 3 | 37 | 32 | 34.666 | 4.010 | 764.49% |
| 2022-12-16 | 2 | 37 | 32 | 34.666 | 4.010 | 764.49% |
| 2023-04-10 | 3 | 44 | 32 | 36.000 | 4.070 | 784.52% |
| 2023-05-09 | 3 | 44 | 32 | 36.000 | 4.620 | 679.22% |
DRRX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 3 | 0 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
DRRX's average broker recommendation rating improved by 0.8 over the prior 21 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for DRRX as an investment opportunity.
- DURECT CORP's upside potential (average analyst target price relative to current price) is greater than 508.86% of all US stocks.
- DRRX has a greater number of analysts covering the stock than 76.97% of all US stocks.
- DURECT CORP's variance in analysts' estimates is lower than -16.28% of Pharmaceutical Products stocks.
- DRRX has a higher average analyst price target than 485.4% of stocks in the small market cap category.
In the Pharmaceutical Products industry, NWBO, ACER, and LXRX are the three stocks most similar to DURECT CORP regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for DRRX? Use POWR Ratings for clearer insight into price direction.